Leading Industry Players
Pfizer Inc. (U.S.), AbbVie (U.S.), Teva Pharmaceuticals (Israel), Merck (U.S.), Bayer Healthcare (Germany), Novartis (Switzerland), Sanofi Aventis (France), and Biogen Idec (U.S.).
Market Research Future postulates that the global multiple sclerosis treatment market is estimated to demonstrate 3.5% CAGR throughout the forecast period (2017-2023). Factors such as increasing patient pool and screening for better treatment options are likely to favor the market growth worldwide. Multiple sclerosis is referred to as an inflammatory, chronic, and an autoimmune disease which generally affects the central nervous system. It especially affects the communication between the brain and other body parts. Multiple sclerosis is a demyelinating disease in which the insulating covers of the nerve cells in the spinal cord and brain are damaged.
Free Sample Copy is Available here @ https://www.marketresearchfuture.com/sample_request/940
Latest Industry News
- GeNeuro has reacquired from the worldwide rights to commercialize and develop the investigational humanized antibody GNbAC1 for the treatment of multiple sclerosis (MS) from Servier. 19 SEP 2018
- Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis. This subtype features neuronal loss but no demyelination of the brain’s white matter. The new categorization provides a better understanding of the individualized nature of the disease. 21 AUG 2018
Global Multiple Sclerosis Treatment Market: Segmental Analysis
By mode of drug type, the global multiple sclerosis treatment market has been segmented into immunosuppressant, immunomodulators, and others.
By mode of the route of administration, the global multiple sclerosis treatment market has been segmented into oral, injectable, and others.
By mode of diagnosis, the global multiple sclerosis treatment market has been segmented into simple electrical stimulation tests, magnetic resonance imaging (MRI) scans, lumbar puncture and others.
By mode of end-users, the global multiple sclerosis treatment market has been segmented into clinics, hospitals, and others.
Among all the regions, America is considered to occupy the largest market share owing to the presence of U.K. in this region. U.S. is estimated to dominate the market due to the increasing R&D activities for better treatment of the disease and extensive development in the medical sector. An increasing number of hospitalization procedures owing to healthcare penetration in Canada and the U.S. are estimated to propel the market growth. Additional factors influencing the market growth are the high concentration of key hospitals and good reimbursement rates.
European is presumed to occupy the second largest market share and is likely to retain its dominance over the years. The growth is credited to the augmenting healthcare industry along with healthcare penetration. The region is mainly led by economies like France and Germany, where Germany is considered to be the fastest growing region due to the presence of its large pharmaceutical industry.
The Asia Pacific is anticipated to expand at a rapid pace and is presumed to lead the market owing to the large unmet needs coupled with the fast-developing healthcare sector in this region. South East Asian economies like India, China, and Malaysia highly contribute to the market growth. Additionally, penetration of the healthcare sector is likely to fuel the future multiple sclerosis market.
Table of Content
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL MULTIPLE SCLEROSIS TREATMENT MARKET, BY DRUG TYPE
Key Questions Answered in This Report:
- What will the market size and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Access the complete report with TOC @
Browse other healthcare-related reports
Oral Thin Film Drugs Market – Global Forecast 2023
by Product (Fast Dissolving Buccal Film, Sublingual), by Disease Indication (Opioid Dependence, Nausea & Vomiting, Schizophrenia, Migraine), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Drug Stores), and Region
Needle-Free Injection Market – Global Forecast 2023
By Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals)
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar